Can cell therapy heal a spinal cord injury?

Spinal Cord

Volumn 46, Issue 8, 2008, Pages 532-539

  Ronsyn, M W ^a,b   Berneman, Z N ^a,b   Van Tendeloo, V F I ^a,b   Jorens, P G ^a,b   Ponsaerts, P ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cell transplantation; Clinical trials; Endogenous neural regeneration; Inflammation; Neurotrophic factors; Spinal cord injury

Indexed keywords

GROWTH PROMOTOR; NEUROTROPHIC FACTOR; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; CELL DIFFERENTIATION; CLINICAL TRIAL; DEMYELINATION; DIABETES MELLITUS; HEART FAILURE; HEART INFARCTION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; NERVE FIBER REGENERATION; NERVE REGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RELATIVE; REVIEW; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; TISSUE TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL TRANSPLANTATION; HUMANS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TISSUE THERAPY;

EID: 49449112443     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2008.13     Document Type: Review

References (50)

1. Wyndaele M, Wyndaele JJ. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord 2006; 44: 523-529.
2. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411.
3. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000; 97: 14720-14725.
4. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999; 5: 1410-1412.
5. Riess P, Molcanyi M, Bentz K, Maegele M, Simanski C, Carlitscheck C et al. Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. J Neurotrauma 2007; 24: 216-225.
6. Akiyama Y, Honmou O, Kato T, Uede T, Hashi K, Kocsis JD. Transplantation of clonal neural precursor cells derived from adult human brain establishes functional peripheral myelin in the rat spinal cord. Exp Neurol 2001; 167: 27-39.
7. Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 2002; 99: 3024-3029.
8. Coumans JV, Lin TT, Dai HN, MacArthur L, McAtee M, Nash C et al. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J Neurosci 2001; 21: 9334-9344.
9. Pinzon A, Calancie B, Oudega M, Noga BR. Conduction of impulses by axons regenerated in a Schwann cell graft in the transected adult rat thoracic spinal cord. J Neurosci Res 2001; 64: 533-541.
10. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
11. Lee J, Kuroda S, Shichinohe H, Ikeda J, Seki T, Hida K et al. Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology 2003; 23: 169-180.
12. Akiyama Y, Radtke C, Kocsis JD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 2002; 22: 6623-6630.
13. Liu C, Chen Z, Chen Z, Zhang T, Lu Y. Multiple tumor types may originate from bone marrow-derived cells. Neoplasia 2006; 8: 716-724.
14. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis MA, McElmurry RT, Bell S et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371-379.
15. Lopez-Vales R, Garcia-Alias G, Fores J, Navarro X, Verdu E. Increased expression of cyclo-oxygenase 2 and vascular endothelial growth factor in lesioned spinal cord by transplanted olfactory ensheathing cells. J Neurotrauma 2004; 21: 1031-1043.
16. Houweling DA, Lankhorst AJ, Gispen WH, Bar PR, Joosten EA. Collagen containing neurotrophin-3 (NT-3) attracts regrowing injured corticospinal axons in the adult rat spinal cord and promotes partial functional recovery. Exp Neurol 1998; 153: 49-59.
17. Bloch J, Fine EG, Bouche N, Zurn AD, Aebischer P. Nerve growth factor- and neurotrophin-3-releasing guidance channels promote regeneration of the transected rat dorsal root. Exp Neurol 2001; 172: 425-432.
18. Kwon BK, Liu J, Lam C, Plunet W, Oschipok LW, Hauswirth W et al. Brain-derived neurotrophic factor gene transfer with adenoassociated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury. Spine 2007; 32: 1164-1173.
19. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003; 181: 115-129.
20. Cao Q, Xu XM, Devries WH, Enzmann GU, Ping P, Tsoulfas P et al. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 2005; 25: 6947-6957.
21. Rosenqvist N, Hård Af Segerstad C, Samuelsson C, Johansen J, Lundberg C. Activation of silenced transgene expression in neural precursor cell lines by inhibitors of histone deacetylation. J Gene Med 2002; 4: 248-257.
22. Facchiano F, Fernandez E, Mancarella S, Maira G, Miscusi M, D'Arcangelo D et al. Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J Neurosurg 2002; 97: 161-168.
23. Lambrechts D, Storkebaum E, Morimoto M, Del Favero J, Desmet F, Marklund SL et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003; 34: 383-394.
24. Benton RL, Whittemore SR. VEGF165 therapy exacerbates secondary damage following spinal cord injury. Neurochem Res 2003; 28: 1693-1703.
25. GrandPre T, Strittmatter SM. Nogo: a molecular determinant of axonal growth and regeneration. Neuroscientist 2001; 7: 377-386.
26. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006; 7: 617-627.
27. Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D, Schwab ME. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 1995; 378: 498-501.
28. Fouad K, Klusman I, Schwab ME. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur J Neurosci 2004; 20: 2479-2482.
29. Prinjha R, Moore SE, Vinson M, Blake S, Morrow R, Christie G et al. Inhibitor of neurite outgrowth in humans. Nature 2000; 403: 383-384.
30. Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci 2001; 21: 4731-4739.
31. Nikulina E, Tidwell JL, Dai HN, Bregman BS, Filbin MT. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci USA 2004; 101: 8786-8790.
32. Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 2002; 22: 6570-6577.
33. Tan AM, Zhang W, Levine JM. NG2: a component of the glial scar that inhibits axon growth. J Anat 2005; 207: 717-725.
34. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636-640.
35. Bethea JR, Nagashima H, Acosta MC, Briceno C, Gomez F, Marcillo AE et al. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 1999; 16: 851-863.
36. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 1999; 158: 351-365.
37. Casha S, Yu WR, Fehlings MG. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001; 103: 203-218.
38. Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C et al. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat Med 2004; 10: 389-395.
39. Wrathall JR, Teng YD, Choiniere D. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Exp Neurol 1996; 137: 119-126.
40. Lammertse D, Tuszynski MH, Steeves JD, Curt A, Fawcett JW, Rask C et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord 2007; 45: 232-242.
41. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 2007; 45: 206-221.
42. Schwab JM, Brechtel K, Mueller CA, Failli V, Kaps HP, Tuli SK et al. Experimental strategies to promote spinal cord regeneration - an integrative perspective. Prog Neurobiol 2006; 78: 91-116.
43. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003; 108: 2212-2218.
44. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221.
45. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
46. Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, Kobayashi S et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res 2005; 80: 182-190.
47. Bakshi A, Hunter C, Swanger S, Lepore A, Fischer I. Minimally invasive delivery of stem cells for spinal cord injury: advantages of the lumbar puncture technique. J Neurosurg Spine 2004; 1: 330-337.
48. Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 1995; 132: 220-228.
49. Anderson KD. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 2004; 21: 1371-1383.
50. Stotts KM. Health maintenance: paraplegic athletes and nonathletes. Arch Phys Med Rehabil 1986; 67: 109-114.